Ex Vivo CRISPR-Cas9 Gene Editing of Donor Liver
3 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Ex Vivo CRISPR-Cas9 Gene Editing of Donor Liver for fatty liver | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Ex Vivo CRISPR-Cas9 Gene Editing of Donor Liver for liver cirrhosis | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Ex Vivo CRISPR-Cas9 Gene Editing of Donor Liver for liver failure | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |